Ormco Announces One-Time U.S. Distribution of Enhanced OrthoPulse Gen.2 Device


Ormco, a leader and innovator of orthodontic products and solutions, announced the unique U.S. distribution of the enhanced OrthoPulse Gen.2 medical device.

Reducing patient treatment time by up to 50%, this gentle, non-invasive system has benefited from structural and technological improvements, such as:

  • Increased battery capacity.
  • Water protection design in charging case and mouthpiece.
  • Plastic chassis for flexible circuit in the mouthpiece to help reduce the risk of wire breakage.
  • Reinforced “Backbone” on the mouthpiece structure.
  • New app version with advanced quality of life updates.

“Through altering a patient’s biological response to treatment, and therefore shortening the orthodontic schedule, patients and physicians alike find this device invaluable, which is why we are delighted to announce that Ormco is the only distributor of the latest version of the already popular OrthoPulse device,” said Jim McGillivary, President of Ormco. “Providing fixed and aligner patients with more comfort and dramatically reducing treatment time – while shortening chair time and increasing predictive results – are all important aspects of our core business.”

“With OrthoPulse’s innovative technology, my patients can safely and effectively accelerate their orthodontic treatment,” said Dr. Jeff Summers. “OrthoPulse fits easily into their daily routine, and we also find it to be soft and comfortable to help reduce pain and discomfort associated with treatment.”

OrthoPulse is a clinically proven, FDA cleared medical device using low levels of light energy to stimulate the bone surrounding the roots of teeth and facilitate tooth movement, accelerating orthodontic treatment with fixed appliances and clear aligners up to at 50%. The device is designed to be used at home by the patient for 10 minutes a day.

To learn more about the OrthoPulse Gen.2, visit ormco.com/orthopulse.


Comments are closed.